Use the Back button in your browser to see the other results of your search or to select another record.
| Functional electrical stimulation to dorsiflexors and plantar flexors during gait to improve walking in adults with chronic hemiplegia |
| Embrey DG, Holtz SL, Alon G, Brandsma BA, McCoy SW |
| Archives of Physical Medicine and Rehabilitation 2010 May;91(5):687-696 |
| clinical trial |
| 4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
OBJECTIVE: To determine whether functional electrical stimulation (FES) timed to activate the dorsiflexors and plantar flexors during gait improves the walking of adults with hemiplegia. DESIGN: Randomized crossover trial. SETTING: Outpatient rehabilitation clinic. PARTICIPANTS: Adults with hemiplegia (N = 28) with a mean age +/- SD of 60 +/- 10.9 years and 4.9 +/- 3.8 years postincident. INTERVENTIONS: Intervention "A" included 3 months of wearing the FES system, which activated automatically during walking for 6 to 8 h/d, 7 d/wk, plus walking 1 h/d, 6 d/wk. Intervention "B" included 3 months of walking 1 h/d, 6 d/wk without FES. Of the 28 patients who completed the study, 15 were randomly assigned to group A-B, 13 to group B-A. Crossover occurred at 3 months. MAIN OUTCOME MEASURES: Variables were measured at pretreatment, 3 months, and 6 months. Three primary outcomes were selected a priori and included 2 functional variables, the 6-minute walk test and the Emory Functional Ambulatory Profile, and 1 participation variable, the Stroke Impact Scale. Secondary impairment measures included muscle strength and spasticity. Assessments were done without electrical stimulation. RESULTS: In phase 1, patients who received treatment A (A-B group) showed improvement compared with patients who received treatment B (B-A group) on the 6-minute walk test (p = 0.02), Emory Functional Ambulatory Profile (p = 0.08), and Stroke Impact Scale (p = 0.03). In phase 2, the A-B group maintained improvement in all 3 primary outcomes even without FES. Both groups improved significantly on all primary outcome measures, comparing 6-month to initial measures (p <= 0.05). CONCLUSIONS: An FES system that stimulates dorsiflexors and plantar flexors similar to the timing of typical adult gait, combined with daily walking, can improve the walking ability of adults with hemiplegia.
|